Short-Term Outcomes After Multisystem Inflammatory Syndrome in Children Treatment

J Pediatric Infect Dis Soc. 2021 Feb 13;10(1):52-56. doi: 10.1093/jpids/piaa151.

Abstract

This is a retrospective chart review of 20 patients treated with a consensus-driven treatment algorithm in multisystem inflammatory syndrome in children patients across a wide clinical spectrum. Their treatments and clinical status are described as well as their favorable return to functional baseline by 30 days post presentation.

Keywords: COVID-19; hospital care; intensive care.

MeSH terms

  • Adolescent
  • Adrenal Cortex Hormones / therapeutic use
  • Algorithms
  • COVID-19 / diagnostic imaging
  • COVID-19 / therapy*
  • COVID-19 Drug Treatment
  • Child
  • Child, Preschool
  • Clinical Protocols*
  • Echocardiography
  • Female
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Infant
  • Male
  • Retrospective Studies
  • SARS-CoV-2
  • Systemic Inflammatory Response Syndrome / diagnostic imaging
  • Systemic Inflammatory Response Syndrome / drug therapy
  • Systemic Inflammatory Response Syndrome / therapy*
  • Treatment Outcome

Substances

  • Adrenal Cortex Hormones
  • Immunoglobulins, Intravenous

Supplementary concepts

  • pediatric multisystem inflammatory disease, COVID-19 related